We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by Lorenzo’s 2 cents. In this article, we will summarize the bulls’ thesis on HIMS. Hims & Hers Health, Inc. (HIMS)’s ...

The goal is to either have the put expire worthless and keep the premium, or to be assigned and acquire the stock below the ...

Hims & Hers has shown impressive revenue growth, accelerating from 46% to 77%. Read why I downgrade HIMS stock from buy to ...

This year's Super Bowl commercials relied on comic relief and highlighted noncontroversial topics, like streaming and entertainment.

The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

Novo Nordisk called out suppliers of compounded weight loss drugs following Hims & Hers’ controversial Super Bowl ad.

Compounded weight-loss medications such as those promoted in the Hims & Hers commercial aren’t approved by the Food and Drug ...

For example, Brittany found that drugs being developed by Generate were modified versions of existing antibodies, and that ...